The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Management and outcomes of 222 CLL patients (pts) treated with venetoclax (VEN) in the real world.
 
Chadi Nabhan
Employment - Cardinal Health
Leadership - Cardinal Health
Stock and Other Ownership Interests - Cardinal Health
 
Andrew Klink
Employment - Cardinal Health
Research Funding - Abbvie (Inst); Amgen (Inst); Array BioPharma (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); EMD Serono (Inst); HERON (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Novartis (Inst)
 
Jennifer Samp
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
James Michael Pauff
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
Travel, Accommodations, Expenses - Abbvie
 
Jackie Nielsen
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Brian Meissner
Employment - Abbvie; Bristol-Myers Squibb
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb
 
Holger Keim
Employment - Abbvie; Amgen
Stock and Other Ownership Interests - Abbvie; Amgen
 
Kaitlin Kennard
Consulting or Advisory Role - Abbvie; Gilead Sciences; Verastem
 
Anthony R. Mato
Consulting or Advisory Role - Abbvie/Genentech; AstraZeneca; Celgene; Janssen; Prime Oncology; TG Therapeutics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); DTRM (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Regeneron (Inst); TG Therapeutics (Inst)